Today we are pleased to welcome Innocens to the Nolqa portfolio. We invested $675K to support the company as it builds its next stage of growth.
What Innocens does
Innocens builds a healthcare software platform that brings hospital data together and applies AI applications to identify early signs of patient deterioration. Its work includes neonatal early-warning applications and tooling intended to help promising clinical AI models move through validation and integration.
Why we invested
We invested because Innocens is addressing a meaningful healthcare challenge with a software-first approach. The company combines clinical expertise, data infrastructure and AI validation in a way that can help turn complex hospital data into information clinicians can use. The potential to support earlier intervention makes the problem especially important.
What comes next
We will support Innocens as it continues clinical validation, strengthens its platform and works toward bringing more AI applications into real-world care.
We are looking forward to working closely with the team and helping Innocens build the next chapter of the business.